| scholarly article | Q13442814 |
| P2093 | author name string | Li Chen | |
| Jing Li | |||
| Ming Zhang | |||
| Wei Li | |||
| Yanjun Liu | |||
| Xiaoyan Lv | |||
| Qiujing Wang | |||
| WenGuang Chang | |||
| Zhaojie Meng | |||
| P2860 | cites work | Efficacy of berberine in patients with type 2 diabetes mellitus | Q24645248 |
| Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 | Q27860575 | ||
| The pivotal role of protein kinase C zeta (PKCzeta) in insulin- and AMP-activated protein kinase (AMPK)-mediated glucose uptake in muscle cells | Q28569456 | ||
| Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion | Q28578447 | ||
| The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin | Q28590162 | ||
| The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism | Q28594811 | ||
| Metformin for type-2 diabetes mellitus. Systematic review and meta-analysis | Q30862920 | ||
| Enhancement of sodium caprate on intestine absorption and antidiabetic action of berberine | Q33773083 | ||
| Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy | Q34535472 | ||
| The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model | Q37036239 | ||
| AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives. | Q37401935 | ||
| Research progress on the mechanism of single-Chinese medicinal herbs in treating diabetes mellitus | Q37848181 | ||
| Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2. | Q40084257 | ||
| Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK. | Q40218653 | ||
| Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states | Q40250572 | ||
| Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine | Q40310290 | ||
| Alteration of 11beta-hydroxysteroid dehydrogenase type 1 in skeletal muscle in a rat model of type 2 diabetes | Q42447239 | ||
| Berberine activates GLUT1-mediated glucose uptake in 3T3-L1 adipocytes | Q42521110 | ||
| Berberine inhibits PTP1B activity and mimics insulin action | Q42826290 | ||
| Berberine stimulates glucose transport through a mechanism distinct from insulin. | Q42831138 | ||
| Berberine modulates insulin signaling transduction in insulin-resistant cells | Q43207012 | ||
| Ameliorative effect of berberine on endothelial dysfunction in diabetic rats induced by high-fat diet and streptozotocin | Q43290690 | ||
| P-glycoprotein-mediated transport of berberine across Caco-2 cell monolayers | Q44218336 | ||
| Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats | Q51404403 | ||
| [Antidiarrheal and anti-inflammatory effects of berberine] | Q69800595 | ||
| P433 | issue | 1-2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | gluconeogenesis | Q191835 |
| hepatic gluconeogenesis | Q106966449 | ||
| P304 | page(s) | 122-130 | |
| P577 | publication date | 2012-08-16 | |
| P1433 | published in | Molecular and Cellular Endocrinology | Q1573600 |
| P1476 | title | Sodium caprate augments the hypoglycemic effect of berberine via AMPK in inhibiting hepatic gluconeogenesis | |
| P478 | volume | 363 |
| Q33819610 | A review of the effects of Berberis vulgaris and its major component, berberine, in metabolic syndrome |
| Q41682189 | Adenovirus vector-mediated macrophage erythroblast attacher (MAEA) overexpression in primary mouse hepatocytes attenuates hepatic gluconeogenesis |
| Q90146179 | Anti-inflammatory Property of AMP-activated Protein Kinase |
| Q28550972 | Berberine Attenuates Development of the Hepatic Gluconeogenesis and Lipid Metabolism Disorder in Type 2 Diabetic Mice and in Palmitate-Incubated HepG2 Cells through Suppression of the HNF-4α miR122 Pathway |
| Q92898827 | Berberine Attenuates Hyperglycemia by Inhibiting the Hepatic Glucagon Pathway in Diabetic Mice |
| Q88881645 | Berberine Improves Cognitive Deficiency and Muscular Dysfunction via Activation of the AMPK/SIRT1/PGC-1a Pathway in Skeletal Muscle from Naturally Aging Rats |
| Q95840735 | Berberine Improves Glucose and Lipid Metabolism in HepG2 Cells Through AMPKα1 Activation |
| Q38410398 | Berberine Pretreatment Confers Cardioprotection Against Ischemia-Reperfusion Injury in a Rat Model of Type 2 Diabetes |
| Q58798574 | Berberine Reduces Pyruvate-driven Hepatic Glucose Production by Limiting Mitochondrial Import of Pyruvate through Mitochondrial Pyruvate Carrier 1 |
| Q33837285 | Berberine Reverses Hypoxia-induced Chemoresistance in Breast Cancer through the Inhibition of AMPK- HIF-1α. |
| Q46480430 | Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling |
| Q38326750 | Berberine as a therapy for type 2 diabetes and its complications: From mechanism of action to clinical studies |
| Q38421650 | Berberine improves insulin resistance in cardiomyocytes via activation of 5′-adenosine monophosphate-activated protein kinase |
| Q35819543 | Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats |
| Q35239952 | Berberine nanosuspension enhances hypoglycemic efficacy on streptozotocin induced diabetic C57BL/6 mice |
| Q54446441 | Cocoa flavonoids improve insulin signalling and modulate glucose production via AKT and AMPK in HepG2 cells |
| Q37741992 | Effect of berberine on the renal tubular epithelial-to-mesenchymal transition by inhibition of the Notch/snail pathway in diabetic nephropathy model KKAy mice |
| Q51019283 | Effects of type 2 diabetes mellitus on the pharmacokinetics of berberine in rats |
| Q55285283 | Elevated hepatic expression of H19 long noncoding RNA contributes to diabetic hyperglycemia. |
| Q38490486 | Gene expression profiling and pathway analysis of hepatotoxicity induced by triptolide in Wistar rats |
| Q48223878 | Genistein represses PEPCK-C expression in an insulin-independent manner in HepG2 cells and in alloxan-induced diabetic mice. |
| Q35008532 | Hematopoietic tissue factor-protease-activated receptor 2 signaling promotes hepatic inflammation and contributes to pathways of gluconeogenesis and steatosis in obese mice |
| Q98464588 | Highly bioavailable Berberine formulation improves Glucocorticoid Receptor-mediated Insulin Resistance via reduction in association of the Glucocorticoid Receptor with phosphatidylinositol-3-kinase |
| Q51282796 | Jiangtang Xiaozhi Recipe () prevents diabetic retinopathy in streptozotocin-induced diabetic rats |
| Q35131343 | Metformin and berberine prevent olanzapine-induced weight gain in rats |
| Q28547147 | Novel Approach to Identify Potential Bioactive Plant Metabolites: Pharmacological and Metabolomics Analyses of Ethanol and Hot Water Extracts of Several Canadian Medicinal Plants of the Cree of Eeyou Istchee |
| Q26752335 | PGC-1α, glucose metabolism and type 2 diabetes mellitus |
| Q61810256 | Unraveling the Regulation of Hepatic Gluconeogenesis |
| Q36988577 | Update on Berberine in Nonalcoholic Fatty Liver Disease |
Search more.